Cost and financing of care for persons with HIV disease: An overview

Health Care Financing Review

Volumn 19, Issue 3, 1998, Pages 5-18

  Hellinger, Fred J ^a  

^a AGENCY FOR HEALTHCARE RESEARCH AND QUALITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; HEALTH CARE COST; HEALTH CARE FINANCING; HEALTH INSURANCE; HOSPITAL CARE; HOSPITAL COST; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; REVIEW;

ANTI-HIV AGENTS; CONTINENTAL POPULATION GROUPS; COST OF ILLNESS; DRUG COSTS; DRUG THERAPY, COMBINATION; FEMALE; HEALTH CARE COSTS; HEALTH SERVICES RESEARCH; HIV INFECTIONS; HIV PROTEASE INHIBITORS; HUMANS; MALE; MEDICAID; SEX FACTORS; SUBSTANCE-RELATED DISORDERS; UNITED STATES;

EID: 0031770499     PISSN: 01958631     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (31)

1. Bartlett, J.G.: Medical Management of HIV Infection, The Johns Hopkins AIDS Service, The Johns Hopkins Medical Institutions. Baltimore, Maryland, 1998.
2. Bartnyska, L.M., Schactman, M., and Hidalgo, J.: Patterns in Maryland Medicaid Enrollment Among Persons with AIDS, Inquiry 32 (2): 184-195, Summer 1995.
3. Carpenter, C.C., Fischl, MA, Hammer, S.M., et al.: Antiretroviral Therapy for HIV Infection in 1996: Recommendations of an International Panel. Journal of the American Medical Association 276(2):146-54, July 10, 1996.
4. Centers for Disease Control and Prevention, National Center for HIV, STD and TB Prevention, Division of STD Prevention: The Challenge Of STD Prevention in the United States. Atlanta. Centers for Disease Control, November 1996a.
5. Centers for Disease Control and Prevention: HIV/AIDS Surveillance Report: U.S. HIV and AIDS Cases Reported Through June 1996, Midyear Edition, Vol. 8, No. 1. Atlanta. Centers for Disease Control, 1996b.
6. Centers for Disease Control and Prevention: HIV/AIDS Surveillance Report: U.S. HIV and AIDS Cases Reported Through June 1997, Midyear Edition, Vol. 9, No. 1. Atlanta. Centers for Disease Control, 1997a.
7. Centers for Disease Control and Prevention: 1997 USPHS/IDSA Guidelines for the Prevention of Opportunistic Infections in Persons with Human Immunodeficiency Virus. Morbidity and Mortality Weekly Report, Volume 46, Number RR-12. Atlanta. Centers for Disease Control, June 27, 1997b.
8. Conviser, R.: Risk Adjustment of Capitated Rates for HIV Under Medicaid Managed Care. Paper presented at the AIDS Managed Care Conference. Baltimore, Maryland. November 17, 1997.
9. Conviser, R., Kerrigan, D., and Thompson, S.: The Adequacy of Reimbursement for HIV under Section 1115 Medicaid Waivers. Bureau of HIV/AIDS, Health Resources and Services Administration, US Department of Health and Human Services. Washington. U.S. Government Printing Office, May 1997.
10. Denning, RH.: Beyond Clinical Trials - Population-Based HIV Viral Load Monitoring and Antiretroviral Therapy. Paper presented at the Fifth Conference on Retroviruses and Opportunistic Infections. Chicago, Illinois. February 5, 1998.
11. Diaz, T., Chu, S., Conti, L., et al.: Health Insurance Coverage among Persons with AIDS: Results from a Multistate Surveillance Project. American Journal of Public Health 84(6):1015-1018, June 1994.
12. Doyle, A., Jefferys, R., and Kelly, J.: National ADAP Monitoring Project: Interim Technical Report. Supported by a grant from The Henry J. Kaiser Family Foundation. Menlo Park, California. March 1998.
13. Dreyfus, T., Kronick, R, and Tobais, C.: Using Payment to Promote Better Medicaid Managed Care for People with AIDS. Prepared for the Henry J. Kaiser Family Foundation. Menlo Park, California. July 1997.
14. Gable, C., Tierce, J., Simison, D., et al.: Costs of HIV/AIDS at CD4+ Counts Disease Stages Based on Treatment Protocols. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology 12(4):413-420, April 1996.
15. Haburchak, D.R : The Economics of AIDS in America. The AIDS Reader 7(5):155-160, May 1997.
16. Health Resources and Services Administration: HIV Capitation Risk Adjustment Conference Report. U.S. Department of Health and Human Services in conjunction with The Henry J. Kaiser Family Foundation. Washington, DC. May 28-29, 1997.
17. Hellinger, EJ.: Forecasting the Medical Care Costs of the HIV Epidemic: 1991-1994. Inquiry 28(3):213-225, Fall 1991.
18. Hellinger, F.J.: Forecasts of the Costs of Medical Care for Persons with HIV: 1992-1995. Inquiry 29(3):356-365, Fall 1992.
19. Hellinger, F.J.: The Lifetime Cost of Treating a Person with HIV. Journal of the American Medical Association 270(4):474-478, July 28, 1993a.
20. Hellinger, F. J.: The Use of Health Services by Women with HIV Infection. Health Services Research, 28(5):543-561, December 1993b.
21. Henke, Klaus-Dirk, Murray, M.A., and Ade, C.: Global Budgeting in Germany: Lessons for the United States. Health Affairs 13(4):7-21, Fall 1994.
22. Holtgrave, D.R., and Pinkerton, S.D.: Updates of Cost of Illness and Quality of life Estimates for Use in Economic Evaluations of HIV Prevention Programs. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology 16(1):54-62, January 1997.
23. Karon, J.M., Rosenberg, P.S., McQuillan, G., et al.: Prevalence of HIV Infection in the United States, 1984 to 1992. Journal of the American Medical Association 276(2):126-131, July 10, 1996.
24. Master, R., Dreyfus, T., Connors, S., et al: The Community Medical Alliance: An Integrated System of Care In Greater Boston for People with Severe Disability and AIDS. Paper presented at the Chronic Care Initiatives in HMOs Conference. Washington, DC. April 27-28, 1995.
25. Moore, R.D., and Chaisson, RE.: Costs to Medicaid of Advancing Immunosuppression in an Urban HIV-Infected Patient Population in Maryland. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology 14(3):223-231, March 1997.
26. New York State Department of Health: AIDS in New York State Through 1994, Albany, NY. 1995.
27. Palella, F.J., Delaney, K.M., Moorman, AC., et al.: Declining Morbidity and Mortality Among Patients with Advanced Human Immunodeficiency Virus Infection. The New England Journal of Medicine 338(13):853-908, March 26, 1998.
28. Ruane, P.J., Ida, J., Zakowski, P.C., et al.: The Impact of New Antiretroviral (ARV) Therapies on Inpatient and Outpatient Utilization of Healthcare Resources in Patients with HIV. Paper presented at the Fourth Conference on Retroviruses and Opportunistic Infections. Washington, DC. January 24, 1997.
29. Weissman, J.S., Clearly, P.D. Seage, G.R., et al.: The Influence of Health-Related Quality of Life and Social Characteristics on Hospital Use by Patients with AIDS in the Boston Health Study. Medical Care 34(10):1037-1056, October 1996.
30. Wennberg, J.E.: Practice Variations and the Challenge to Leadership. Spine 21(12):1472-1478, June 15, 1996.
31. Wennberg, J.E.: Future Directions for Small Area Variations. Medical Care 31 (5 Supplement) :YS75-80, May 1993.